Douglas Kriner

Douglas Kriner


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in JAMA Network Open
Verified
Journal Article
Closed access
PDF file
SKSarah Kreps
Sarah Kreps
SPSandip Prasad
Sandip Prasad
JBJohn S. Brownstein
John S. Brownstein
YHYulin Hswen
Yulin Hswen
BGBrian T. Garibaldi
Brian T. Garibaldi
DKDouglas Kriner
Douglas Kriner
In April 2020, the United States established Operation Warp Speed to develop a coronavirus disease 2019 (COVID-19) vaccine and produce 300 million doses by January 2021. History suggests that the initiative is aptly named. As Barney S. Graham notes, “Vaccine development is usually measured in decades, so having access to approved vaccines available for large-scale distribution before the end of 2020 or even 2021 would be unprecedented.”1

23 October 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
SKSarah Kreps
Sarah Kreps
DKDouglas Kriner
Douglas Kriner
Communications engaging uncertainty in COVID-19 research affect public trust in science and support for science-based policy.

14 May 2021 in npj Vaccines
Verified
Journal Article
Open access
PDF file
SKSarah Kreps
Sarah Kreps
NDNabarun Dasgupta
Nabarun Dasgupta
JBJohn S. Brownstein
John S. Brownstein
YHYulin Hswen
Yulin Hswen
DKDouglas Kriner
Douglas Kriner
While efficacious vaccines have been developed to inoculate against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; also known as COVID-19), public vaccine hesitancy could still undermine efforts to combat the pandemic. Employing a survey of 1096 adult Americans recruited via the Lucid platform, we examined the relationships between vaccine attributes, proposed policy interventions such as financial incentives, and misinformation on public vaccination preferences. Higher degrees of vaccine efficacy significantly increased individuals’ willingness to receive a COVID-19 vaccine, while a high incidence of minor side effects, a co-pay, and Emergency Use Authorization to fast-track the vaccine decreased willingness. The vaccine manufacturer had no influence on public willingness to vaccinate. We also found no evidence that belief in misinformation about COVID-19 treatments was positively associated with vaccine hesitancy. The findings have implications for public health strategies intending to increase levels of community vaccination.


15 February 2022 in Public Opinion Quarterly
Verified
Journal Article
Closed access
PDF file
SKSarah E Kreps
Sarah E Kreps
DKDouglas Kriner
Douglas Kriner
The COVID-19 pandemic has prompted social media platforms to take unprecedented steps—ranging from false tags to journalistic factchecks—to stanch the flow of misinformation that could pose a health risk. However, there is little evidence about the relative efficacy of these approaches in this unique context of a pandemic. Using a pair of survey experiments, we examine whether false tags and journalistic factchecks reduce accuracy misperceptions and sharing propensity on social media that can spread false claims. False tags had little effect on subjects’ accuracy assessments and social media sharing. Journalistic factchecks that offer accurate information to counter misinformation were more effective in reducing both misperceptions and sharing on social media. Further, we find no evidence of partisan backfire effects, even in response to interventions against claims with a plausible partisan valence. Our results suggest that journalistic factchecks provide an effective counternarrative to COVID-19 misinformation even in the context of the increasing politicization of America’s pandemic response and polarization more generally.

13 August 2021 in Vaccines
Verified
Journal Article
Open access
PDF file
SKSarah Kreps
Sarah Kreps
JGJillian Goldfarb
Jillian Goldfarb
JBJohn S. Brownstein
John S. Brownstein
DKDouglas Kriner
Douglas Kriner
While mass vaccination has blunted the pandemic in the United States, pockets of vaccine hesitancy remain. Through a nationally representative survey of 1027 adult Americans conducted in February 2021, this study examined individual misconceptions about COVID-19 vaccine safety; the demographic factors associated with these misconceptions; and the relationship between misconceptions and willingness to vaccinate. Misconceptions about vaccine safety were widespread. A sizeable minority (40%) believed that vaccine side effects are commonly severe or somewhat severe; 85% significantly underestimated the size and scale of the clinical trials; and a sizeable share believed either that the vaccines contain live coronavirus (10%) or were unsure (38%), a proxy for fears that vaccination itself may cause infection. These misconceptions were particularly acute among Republicans, Blacks, individuals with lower levels of educational attainment, and unvaccinated individuals. Perceived side effect severity and underestimating the size of the clinical trials were both significantly associated with vaccine hesitancy.